Mariner Portfolio holdings
AUM
$69.3B
This Quarter Return
+6.54%
1 Year Return
+18.98%
3 Year Return
+74.86%
5 Year Return
+121.64%
10 Year Return
+220.27%
AUM
$56.4B
AUM Growth
+$56.4B
(+9.3%)
Cap. Flow
+$2.47B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
25.87%
Holding
3,434
New
281
Increased
1,729
Reduced
1,173
Closed
149
Top Buys
| 1 |
Broadcom
AVGO
|
$524M |
| 2 |
Microsoft
MSFT
|
$255M |
| 3 |
NVIDIA
NVDA
|
$149M |
| 4 |
Trane Technologies
TT
|
$107M |
| 5 |
lululemon athletica
LULU
|
$94.2M |
Top Sells
| 1 |
Apollo Global Management
APO
|
$235M |
| 2 |
Nike
NKE
|
$126M |
| 3 |
Jacobs Solutions
J
|
$74.3M |
| 4 |
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
|
$41.1M |
| 5 |
3M
MMM
|
$30.4M |
Sector Composition
| 1 | Technology | 19.46% |
| 2 | Financials | 7.32% |
| 3 | Healthcare | 5.85% |
| 4 | Consumer Discretionary | 5.33% |
| 5 | Industrials | 4.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3201
indie Semiconductor
INDI
$899M
| $41.7K | ﹤0.01% |
+10,447
| New | +$41.7K |
|
3202
Enel Chile
ENIC
$4.83B
| $41.6K | ﹤0.01% |
14,888
-2,100
| -12% | -$5.86K |
|
3203
Relmada Therapeutics
RLMD
$37.2M
| $39.8K | ﹤0.01% |
12,274
-4,945
| -29% | -$16K |
|
3204
Editas Medicine
EDIT
$231M
| $39.4K | ﹤0.01% |
+11,554
| New | +$39.4K |
|
3205
Blink Charging
BLNK
$124M
| $39.2K | ﹤0.01% |
22,783
+2,010
| +10% | +$3.46K |
|
|
IMAB
3206
I-MAB
IMAB
$340M
| $39.1K | ﹤0.01% |
31,535
| – | – |
|
3207
Twin Vee PowerCats
VEEE
$4.36M
| $38.5K | ﹤0.01% |
64,118
+45,000
| +235% | +$27K |
|
3208
Bit Digital
BTBT
$826M
| $37.8K | ﹤0.01% |
+10,752
| New | +$37.8K |
|
3209
Cardlytics
CDLX
$54.3M
| $37.4K | ﹤0.01% |
11,700
-3,323
| -22% | -$10.6K |
|
3210
Rapid Micro Biosystems
RPID
$107M
| $37.4K | ﹤0.01% |
+42,000
| New | +$37.4K |
|
|
NB
3211
NioCorp Developments
NB
$334M
| $35.6K | ﹤0.01% |
16,338
-864
| -5% | -$1.88K |
|
|
AILE
3212
DELISTED
iLearningEngines, Inc. Common Stock
AILE
| $35.1K | ﹤0.01% |
+21,045
| New | +$35.1K |
|
3213
ProQR Therapeutics
PRQR
$237M
| $33.5K | ﹤0.01% |
18,334
| – | – |
|
3214
Grupo Aval
AVAL
$3.96B
| $33.3K | ﹤0.01% |
16,394
-178,443
| -92% | -$362K |
|
3215
Talkspace
TALK
$445M
| $32K | ﹤0.01% |
15,314
+314
| +2% | +$656 |
|
3216
CureVac
CVAC
$1.21B
| $30.8K | ﹤0.01% |
10,312
-5,327
| -34% | -$15.9K |
|
|
DHY
3217
Credit Suisse High Yield Bond Fund
DHY
$217M
| $30.5K | ﹤0.01% |
+13,455
| New | +$30.5K |
|
3218
Chegg
CHGG
$159M
| $29.3K | ﹤0.01% |
16,547
-872
| -5% | -$1.54K |
|
|
BLUE
3219
DELISTED
bluebird bio
BLUE
| $28.8K | ﹤0.01% |
55,446
| – | – |
|
|
KG
3220
Kestrel Group, Ltd.
KG
$209M
| $28.1K | ﹤0.01% |
15,889
+509
| +3% | +$901 |
|
3221
Taysha Gene Therapies
TSHA
$797M
| $26.8K | ﹤0.01% |
+13,336
| New | +$26.8K |
|
3222
Atomera
ATOM
$103M
| $26.3K | ﹤0.01% |
+10,000
| New | +$26.3K |
|
3223
Bolt Biotherapeutics
BOLT
$9.85M
| $26.3K | ﹤0.01% |
+40,535
| New | +$26.3K |
|
3224
LivePerson
LPSN
$90.1M
| $26.1K | ﹤0.01% |
20,397
+400
| +2% | +$512 |
|
3225
Oramed Pharmaceuticals
ORMP
$90.2M
| $25.7K | ﹤0.01% |
10,544
| – | – |
|